15 March 2023 : Clinical Research
Alterations in Amygdala/Hippocampal Volume Ratios in Children with Obstructive Sleep Apnea Syndrome Caused by Adenotonsillar Hypertrophy
Yanshan Ma1ABCE, Zheli Niu2ABCE, Lin Ruan2CDF, Sisi Xue3CDF, Nan Li3F, Xiaoguang Yao 3ABCE, Qiang Li 3AEFG*DOI: 10.12659/MSM.937420
Med Sci Monit 2023; 29:e937420
Table 1 Demographic characteristics and clinical variables of subjects.
Category | ATH/OSA (n=100) | Controls (n=100) | P value | |
---|---|---|---|---|
Age (y) | Mean (95% CI) | 5. 74 (5.14, 6.35) | 5.95 (5.35, 6.55) | 0.57 |
BMI z score | Mean (95% CI) | 0.37 (0.23, 0.52) | 0.32 (0.19, 0.45) | 0.57 |
Gender | Male/female | 68/32 | 65/35 | 0.38 |
Smoking status in family | y/n | 93/7 | 90/10 | 0.31 |
Asthma | y/n | 5/95 | 0/100 | 0.024 |
Chronic or allergic rhinitis | y/n | 14/86 | 0/100 | 0.000 |
Food/drug allergy | y/n | 7/93 | 5/95 | 0.552 |
Eosinophil count (μL) | 289.15±67.10 | 279.12±51.64 | 0.237 | |
Total serum IgE (U/mL) | 251.27±63.21 | 236.42±66.95 | 0.108 | |
Amygdala volume | cm | 2.65±0.21 | 2.17±0.18 | 0.000 |
Hippocampus volume | cm | 7.08±0.11 | 7.29±0.15 | 0.000 |
A/H ratio | 0.37±0.03 | 0.30±0.02 | 0.000 | |
Tonsil hypertrophy | ||||
I° | N (%) | 19 (19%) | ||
II° | N (%) | 68 (68%) | ||
III° | N (%) | 13 (13%) | ||
Adenoid hypertrophy | ||||
I° | N (%) | 5 (5%) | ||
II° | N (%) | 30 (30%) | ||
III° | N (%) | 58 (58%) | ||
IV° | N (%) | 7 (7%) | ||
A/N ratio | Mean (95% CI) | 0.85 (0.83, 0.86) | 0.56 (0.55, 0.57) | 0.000 |
Disease duration(months) | Mean (95% CI) | 3.25 (2.96, 3.54) | ||
Polysomnography variables | ||||
Mean SaO2 | (%) | 95.33±2.41 | ||
AHI | 33.25±24.86 | |||
min Sao2 | (%) | 74.87±12.62 | ||
Percentage of SaO2<90% | (%) | 10.24±8.79 | ||
The data of the clinical variables and demographic characteristics are expressed as the mean±standard deviation (SD) for continuous variables when the data were normally distributed, as a 95% confidence interval (CI) when the data had a skewed distribution, or counts (percentages) for discrete variables. |